These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22594902)

  • 21. Druggable signaling proteins.
    Sioud M; Leirdal M
    Methods Mol Biol; 2007; 361():1-24. PubMed ID: 17172705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel Agents in the Treatment of Thymic Malignancies.
    Merveilleux du Vignaux C; Maury JM; Girard N
    Curr Treat Options Oncol; 2017 Aug; 18(9):52. PubMed ID: 28795288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absence of gene mutations in KIT-positive thymic epithelial tumors.
    Tsuchida M; Umezu H; Hashimoto T; Shinohara H; Koike T; Hosaka Y; Eimoto T; Hayashi JI
    Lung Cancer; 2008 Dec; 62(3):321-5. PubMed ID: 18486988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular mechanisms of signal transduction: epidermal growth factor receptor family, vascular endothelial growth factor family, Kit, platelet-derived growth factor receptor, Ras.
    Erman M
    J BUON; 2007 Sep; 12 Suppl 1():S83-94. PubMed ID: 17935283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thymic epithelial tumours: from basic principles to individualised treatment strategies.
    Girard N
    Eur Respir Rev; 2013 Mar; 22(127):75-87. PubMed ID: 23457169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current Drug Targets for Thymic Neoplasms.
    Xu XL; Mao WM
    Curr Cancer Drug Targets; 2015; 15(7):593-603. PubMed ID: 26077729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical management of thymoma patients.
    Casey EM; Kiel PJ; Loehrer PJ
    Hematol Oncol Clin North Am; 2008 Jun; 22(3):457-73. PubMed ID: 18514127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic treatment of malignant thymoma: a decade experience at a single institution.
    Giaccone G; Wilmink H; Paul MA; van der Valk P
    Am J Clin Oncol; 2006 Aug; 29(4):336-44. PubMed ID: 16891859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thymic carcinoma: outcomes after surgical resection.
    Okereke IC; Kesler KA; Freeman RK; Rieger KM; Birdas TJ; Ascioti AJ; Badve S; Nelson RP; Loehrer PJ
    Ann Thorac Surg; 2012 May; 93(5):1668-72; discussion 1672-3. PubMed ID: 22421590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thymic carcinoma in children: a report from the Polish Pediatric Rare Tumors Study.
    Stachowicz-Stencel T; Bien E; Balcerska A; Godzinski J; Synakiewicz A; Madziara W; Perek-Polnik M; Peregud-Pogorzelski J; Pietras W; Pobudejska A; Kurylak A; Mankowski P
    Pediatr Blood Cancer; 2010 Jul; 54(7):916-20. PubMed ID: 20405512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New therapeutic targets in melanoma.
    Martí RM; Sorolla A; Yeramian A
    Actas Dermosifiliogr; 2012 Sep; 103(7):579-90. PubMed ID: 22261672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for refractory cases: a review.
    Ozkan EE
    Mol Cell Endocrinol; 2011 Sep; 344(1-2):1-24. PubMed ID: 21782884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thymic carcinoma: a report of 13 cases.
    Lucchi M; Mussi A; Ambrogi M; Gunfiotti A; Fontanini G; Basolo F; Angeletti CA
    Eur J Surg Oncol; 2001 Nov; 27(7):636-40. PubMed ID: 11669591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current chemotherapy options for thymic epithelial neoplasms.
    Papadopoulos KP; Thomas CR
    Expert Opin Pharmacother; 2005 Jun; 6(7):1169-77. PubMed ID: 15957970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thymic malignancies: from clinical management to targeted therapies.
    Kelly RJ; Petrini I; Rajan A; Wang Y; Giaccone G
    J Clin Oncol; 2011 Dec; 29(36):4820-7. PubMed ID: 22105817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted therapy of hepatocellular carcinoma: present and future.
    Chan SL; Yeo W
    J Gastroenterol Hepatol; 2012 May; 27(5):862-72. PubMed ID: 22369685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidermal growth factor receptor pathway targeted therapy in patients with aerodigestive malignancies.
    Patel JD
    Curr Opin Oncol; 2006 Nov; 18(6):609-14. PubMed ID: 16988582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thymic epithelial tumor medical treatment: A narrative review.
    Huang Q; Zhu L; Liu Y; Zhang Y
    Biochim Biophys Acta Rev Cancer; 2024 Sep; 1879(5):189167. PubMed ID: 39117091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Responses to targeted therapies: lung cancer].
    Brambilla E
    Ann Pathol; 2009 Nov; 29 Spec No 1():S77-80. PubMed ID: 19887261
    [No Abstract]   [Full Text] [Related]  

  • 40. [Chemotherapy in disseminated thymoma--case report, own experience].
    Mrochen-Domin I; Chmielik E; Starzyczny-Słota D; Nowara E; Sikora M
    Pneumonol Alergol Pol; 2011; 79(3):222-6. PubMed ID: 21509735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.